Marshall Wace’s Strata Critical Medical Inc SRTA Stock Holding History

Marshall Wace’s Portfolio SRTA Stock Details SRTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-144,167	Closed	-$581K	–	2904
2025 Q2	$581K	Buy	+144,167	New	+$469K	﹤0.01%	2093
2025 Q1	–	Sell	-452,445	Closed	-$1.92M	–	2634
2024 Q4	$1.92M	Buy	452,445 +356,596	+372%	+$1.36M	﹤0.01%	1453
2024 Q3	$282K	Buy	+95,849	New	+$305K	﹤0.01%	2172
2024 Q2	–	Sell	-21,314	Closed	-$60.7K	–	2557
2024 Q1	$60.7K	Buy	+21,314	New	+$65.8K	﹤0.01%	2335
2023 Q2	–	Sell	-12,133	Closed	-$41K	–	2485
2023 Q1	$41K	Buy	+12,133	New	+$49.5K	﹤0.01%	2549
2021 Q4	–	Sell	-113,237	Closed	-$1.18M	–	3866
2021 Q3	$1.18M	Buy	113,237 +3,070	+3%	+$26.8K	﹤0.01%	1921
2021 Q2	$1.16M	Buy	+110,167	New	+$1.09M	0.01%	1740
2021 Q1	–	Sell	-851,708	Closed	-$9.44M	–	2483
2020 Q4	$9.44M	Buy	851,708 +351,710	+70%	+$3.59M	0.05%	368
2020 Q3	$5.03M	Buy	+499,998	New	+$5.05M	0.03%	518

Other funds holding SRTA

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Third Point New York $2.08B AUM 27.04% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AIC

AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Marshall Wace's SRTA Position: Q3 2025 in Review

Marshall Wace sold out of Strata Critical Medical Inc (SRTA) in Q3 2025, closing a stake of 144,167 shares — an estimated $581K sold.

Marshall Wace first reported a position in SRTA in Q3 2020 and held it in 9 quarters. The position peaked at $9.44M in Q4 2020. 137 funds tracked by Wall St. Rank hold SRTA as of Q3 2025.

Marshall Wace reported no remaining Strata Critical Medical Inc position as of Q3 2025 after selling out during the quarter.
Marshall Wace sold 144,167 Strata Critical Medical Inc shares in Q3 2025, an estimated $581K.
Marshall Wace first reported a position in Strata Critical Medical Inc in Q3 2020 and held it in 9 quarters.
Marshall Wace's Strata Critical Medical Inc position peaked at $9.44M in Q4 2020.
137 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q3 2025.

Based on Marshall Wace's 13F filing for Q3 2025, filed 13 Nov 2025.